Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page
- ChecktodayChange DetectedThe Study Details page gains recruitment status and guidance sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0; the existing 'Intervention/Treatment' section is removed and the prior v3.5.5 revision note is eliminated.SummaryDifference0.4%

- Check8 days agoChange DetectedRevision label on the page updated from v3.5.4 to v3.5.5, reflecting a recent site deployment.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This appears to be a minor metadata/template update with no effect on the study details or user-facing information.SummaryDifference0.0%

- Check43 days agoChange DetectedThe site revision has been updated to v3.5.3, replacing the previous v3.5.2. This appears to be a minor platform release and does not alter the study information or its presentation on the page.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.